(Q39374605)

11 September 2017

title

Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma (English)

1 reference

11 September 2017

0 references

budesonide/formoterol

1 reference

2

1 reference

11 September 2017

Paul M O'Byrne

1

0 references

author name string

Philippe P Godard

3

1 reference

11 September 2017

Massimo Pistolesi

4

1 reference

11 September 2017

Mona Palmqvist

5

1 reference

11 September 2017

Yuanjue Zhu

6

1 reference

11 September 2017

Tommy Ekström

7

1 reference

11 September 2017

Eric D Bateman

8

1 reference

11 September 2017

language of work or name

English

0 references

publication date

22 October 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

11 September 2017

published in

1 reference

11 September 2017

volume

171

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

129-136

1 reference

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Effect of long‐acting β2 agonists on exacerbation rates of asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Potential masking effects of salmeterol on airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-884OC

10.1164/RCCM.200407-884OC

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference